Globus MedicalGMED
About: Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.
Employees: 5,300
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
218% more call options, than puts
Call options by funds: $13.7M | Put options by funds: $4.32M
41% more repeat investments, than reductions
Existing positions increased: 200 | Existing positions reduced: 142
35% more first-time investments, than exits
New positions opened: 93 | Existing positions closed: 69
2% more funds holding
Funds holding: 494 [Q4 2024] → 506 (+12) [Q1 2025]
1.24% less ownership
Funds ownership: 95.73% [Q4 2024] → 94.48% (-1.24%) [Q1 2025]
5% less funds holding in top 10
Funds holding in top 10: 19 [Q4 2024] → 18 (-1) [Q1 2025]
12% less capital invested
Capital invested by funds: $9.01B [Q4 2024] → $7.96B (-$1.05B) [Q1 2025]
Research analyst outlook
4 Wall Street Analysts provided 1 year price targets over the past 3 months
4 analyst ratings
Canaccord Genuity William Plovanic | 68%upside $90 | Buy Maintained | 22 Jul 2025 |
Morgan Stanley Drew Ranieri | 27%upside $68 | Overweight Maintained | 15 Jul 2025 |
Truist Securities Richard Newitter | 27%upside $68 | Hold Maintained | 12 May 2025 |
Piper Sandler Matt O'Brien | 50%upside $80 | Overweight Maintained | 9 May 2025 |
Financial journalist opinion
Based on 5 articles about GMED published over the past 30 days









